Nanox (NASDAQ: NNOX) announced plans to showcase its medical imaging technologies at the Radiological Society of North America (“RSNA”) 2026 Annual Meeting, scheduled for Nov. 29 through Dec. 2 in Chicago. At booth #1759 (South Hall Level 3), the company will demonstrate Nanox.ARC X, its U.S. Food and Drug Administration (“FDA”)-cleared multi-source digital tomosynthesis system recognized among TIME’s Best Inventions of 2026, alongside Nanox.AI, which uses FDA-cleared artificial intelligence (“AI”) algorithms to analyze routine computed tomography (“CT”) scans for early signs of chronic conditions. Nanox will also highlight its USARAD teleradiology services and Nanox Health IT solutions.
The company plans to preview innovations under development, including multiplanar and volumetric reconstruction, pediatric imaging indications and Mobile Nanox.ARC, as well as AI-based aortic valve calcification assessment and body composition. These developmental capabilities are not cleared or approved for clinical use, and features, indications and availability may change. Nanox CEO Erez Meltzer and Lawrence Tanenbaum, MD, Chief Medical Officer, U.S., Nanox, will deliver an Industry Expert Theater presentation on Nov. 30 at 10:30 am CT, followed by an Innovation Theater presentation on Dec. 1 at 11:00 am CT by Cedars-Sinai cardiologist Ofir Koren, MD, highlighting an aortic valve calcification AI solution.
To view the full press release, visit https://ibn.fm/M2sbi
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.
Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.
Nanox’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.
The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
NOTE TO INVESTORS: The latest news and updates relating to NNOX are available in the company’s newsroom at http://ibn.fm/NNOX
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN











